Preexisting autoimmune diseases are tied to shorter hospital stays and less toxicity risk in patients receiving chimeric ...
AP Newsroom on MSN
How CAR-T therapy works in autoimmune diseases
CAR-T therapy was originally developed for leukemias and lymphomas, and the breakthrough treatment is now also being used for ...
Frederick L. Locke, MD, chair in the department of blood and marrow transplant and cellular immunotherapy at Moffitt Cancer ...
The treatment landscape for systemic lupus erythematosus (SLE) has shifted greatly in recent years, driven by the emergence ...
A new study from the Icahn School of Medicine at Mount Sinai helps explain why some people with multiple myeloma, a type of ...
Only a few dozen patients with lupus have been treated with CAR-T-cell therapy — but in a small German study, all five ...
“Utilizing real-world data, technology, strategic solutions, and cross-departmental partnerships will help ensure equitable access, so the right member receives the right drug at the right time and ...
A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...
A Stakeholder Interchange convened in Los Angeles, California, by The American Journal of Managed Care explores the treatment ...
A UK MS patient is the first to receive CAR T-cell therapy, offering new hope to halt disease progression and reset the immune system.
A new study from the Icahn School of Medicine at Mount Sinai helps explain why some people with multiple myeloma, a type of blood cancer, stay in remission for many years after receiving CAR T cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback